Abstract:Background: Alzheimer's disease (AD) has attracted more and more attention in recent years. Accurate diagnosis of AD is significant, especially its prodromal stage, i.e., mild cognitive impairment (MCI), for timely therapy is possibly beneficial to delay the disease progression. Some existing studies indicated that different biomarkers provide complementary information to discriminate MCI patients from healthy normal controls (NCs), but the high complexity of these algorithms brought high computational cost. Objective: To identify Alzheimer's disease in its early stage with a low computational complexity where the complementary of different biomarkers can still be used. Method: In this work, we employ the methodology of ensemble learning to construct a two-stage classifier for combining the classification capacity of three biomarkers, i.e., magnetic resonance imaging (MRI), positron emission tomography (PET), and quantification of specific proteins measured through cerebrospinal fluid (CSF), to identify MCIs from healthy controls based on support vector machines algorithm. In the first stage, two SVM classifiers based on MRI and CSF are used for the identification of MCI, respectively. For the samples which can get the same results in the first stage will be seen as the training data, and the ones with the inconsistent result will be put into the second stage as the test data, where PET features are adapted to the classification. Results: An original dataset downloaded from ADNI database, where 99 MCI patients and 52 healthy controls included, had been adopted for the validation of our proposed method. The experimental results demonstrated the effectiveness of the two-stage ensemble classifier with a classification accuracy of 75.5%, a sensitivity of 78.4% and a specificity of 70.0%. Conclusion: This study proposed a computational framework to identify the early stage of AD by a two-stage ensemble strategy. The performance of this work shows that combination of different biomarkers can improve identification of MCI with a relatively low computational cost, which is very meaningful for the diagnosis and delay of the AD progress.

Early Diagnosis of Alzheimer's Disease by Ensemble Deep Learning Using FDG-PET

Introducing an ensemble method for the early detection of Alzheimer's disease through the analysis of PET scan images

Early Diagnosis of Alzheimer's Disease Using Deep Learning

Ensemble of Deep Convolutional Neural Networks Based Multi-Modality Images for Alzheimer's Disease Diagnosis

Early Diagnosis of Alzheimer’s Disease Based on Selective Kernel Network with Spatial Attention

Ensemble deep learning approach for early diagnosis of Alzheimer's disease

Broad learning for early diagnosis of Alzheimer's disease using FDG-PET of the brain

Classification of Alzheimer’s Disease by Combination of Convolutional and Recurrent Neural Networks Using FDG-PET Images

Multi-scale discriminative regions analysis in FDG-PET imaging for early diagnosis of Alzheimer's disease

Multi-scale Discriminative Regions Analysis in FDG-PET Imaging for Early Diagnosis of Alzheimer’s Disease

A Multi-Scale Feature Selection Module Based Architecture for the Diagnosis of Alzheimer’s Disease on [18F]FDG PET

Deep-learning-based classification of FDG-PET data for Alzheimer's disease categories.

A multi-scale feature selection module based architecture for the diagnosis of Alzheimer's disease on [18F]FDG PET

Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer's Disease using structural MR and FDG-PET images

Ensemble learning using traditional machine learning and deep neural network for diagnosis of Alzheimer's disease

Bilinear pooling and metric learning network for early Alzheimer's disease identification with FDG-PET images

Early Diagnosis of Alzheimer's Disease Based on Resting-State Brain Networks and Deep Learning

Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images.

Development and validation of a deep-broad ensemble model for early detection of Alzheimer's disease

Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images

Early Stage Identification of Alzheimer's Disease Using a Two-stage Ensemble Classifier